We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Boosting the Efficacy of A Key Cancer Treatment

News   Feb 21, 2017 | Original story from Sbarro Health Research Organization

 
Boosting the Efficacy of A Key Cancer Treatment

MicroRNA-125a-5p is a downstream effector of sorafenib in its antiproliferative activity toward human hepatocellular carcinoma cells. Credit: Sbarro Health Research Organization

 
 
 

RELATED ARTICLES

Protein Prevents Neuropathy From Chemotherapy

News

A team of researchers has discovered a novel protein that is capable of preventing the development of neuropathy in cancer patients who receive chemotherapy.

READ MORE

Protein Participates in Shift From “Fatty Liver” to Cancer

News

A protein has been discovered that is involved in the progression of a "fatty liver" to cancer. The protein "S100A11" could be harnessed as a means for early detection of cancer risk and could aid the development of new targeted therapies.

READ MORE

Stop or Go: How a Cell Maintains its Fine Motility Balance

News

Researchers identified a protein called tropomodulin as a key player in maintaining the balance between actin-filament machineries within a cell.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE